|
CAMK2G expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.92419430284008E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
3.39660000125974E-09 |
| Normal-vs-Stage3 |
1.75529590862311E-11 |
| Normal-vs-Stage4 |
1.55410000002298E-06 |
| Stage1-vs-Stage2 |
9.050600E-01 |
| Stage1-vs-Stage3 |
5.501200E-01 |
| Stage1-vs-Stage4 |
9.408000E-01 |
| Stage2-vs-Stage3 |
5.228800E-01 |
| Stage2-vs-Stage4 |
8.624200E-01 |
| Stage3-vs-Stage4 |
7.449200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.14519529812196E-11 |
| Normal-vs-Asian |
5.961300E-03 |
| Caucasian-vs-AfricanAmerican |
6.282000E-01 |
| Caucasian-vs-Asian |
2.940600E-01 |
| AfricanAmerican-vs-Asian |
4.387800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
3.87419999969829E-07 |
| Male-vs-Female |
1.817210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.38370434502144E-11 |
| Normal-vs-Extreme_Weight |
6.08069150587198E-13 |
| Normal-vs-Obese |
9.99200722162641E-16 |
| Normal-vs-Extreme_Obese |
2.24989999964009E-07 |
| Normal_Weight-vs-Extreme_Weight |
7.585200E-01 |
| Normal_Weight-vs-Obese |
4.422000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.132800E-01 |
| Extreme_Weight-vs-Obese |
1.069030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.011200E-01 |
| Obese-vs-Extreme_Obese |
4.809200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.63290000002137E-06 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
4.61852778244065E-14 |
| Normal-vs-Age(81-100Yrs) |
3.72668562675926E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.716000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.676000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.239200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.205600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.599550E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.522350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.38697950294409E-14 |
| Normal-VS-KIRP CIMP |
2.12309999999549E-05 |
| Normal-VS-Unclassified PRCC |
4.30089996950045E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.418400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.628000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.922820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.098600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.748300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.757400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.2085445411667E-14 |
| Normal-vs-N1 |
3.04659999450507E-08 |
| Normal-vs-N2 |
2.941200E-03 |
| N0-vs-N1 |
5.219600E-01 |
| N0-vs-N2 |
7.952600E-01 |
| N1-vs-N2 |
9.617200E-01 |
|
|
